Berberine in Cardiovascular and Metabolic Diseases: From Mechanisms to Therapeutics
Open accessAbstract
Cardiovascular and metabolic diseases (CVMD) are the leading causes of death worldwide, underscoring the urgent necessity to develop new pharmacotherapies. Berberine (BBR) is an eminent component of traditional Chinese and Ayurvedic medicine for more than 2000 years. Recently, BBR has attracted much interest for its pharmacological actions in treating and/or managing CVMD. Recent discoveries of basic, translational and clinical studies have identified many novel molecular targets of BBR (such as AMPK, SIRT1, LDLR, PCSK9, and PTP1B) and provided novel evidences supporting the promising therapeutic potential of BBR to combat CVMD. Thus, this review provides a timely overview of the pharmacological properties and therapeutic application of BBR in CVMD, and underlines recent pharmacological advances which validate BBR as a promising lead drug against CVMD.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Berberine stabilizes LDL receptor mRNA to increase the clearance rate of plasma LDL.
“In addition, berberine stabilizes LDL receptor mRNA to increase the clearance rate of plasma LDL [80].”
From The Effect of Berberine on Metabolic Profiles in Type 2 Diabetic Patients: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials (2021) · cites this paper as [80]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
3 retracted
Xie, Z., Zhang, J., Wu, J., Viollet, B., & Zou, M. (2008) · Diabetes · doi:10.2337/db08-0610 · Cited by 163 · see citing works
RetractedLan, T., Shen, X., Liu, P., Liu, W., Xu, S., Xie, X. S., Jiang, Q. L., Li, W., & Huang, H. (2010) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2010.07.012 · Cited by 80 · see citing works
Self-citationRetractedBerberine Improves Kidney Function in Diabetic Mice via AMPK Activation
Zhao, L., Sun, L., Nie, H., Wang, X., & Guan, G. (2014) · PLoS ONE · doi:10.1371/journal.pone.0113398 · Cited by 37 · see citing works
RetractedToprak, Ö., Kurt, H., Sarı, Y., Şarkış, C., Us, H., & Kırık, A. (2017) · Kidney & Blood Pressure Research · doi:10.1159/000468530 · Cited by 29,769 · see citing works
Diagnosis and Classification of Diabetes Mellitus
Basevi, V. (2011) · Diabetes Care · doi:10.2337/dc11-s062 · Cited by 21,302 · see citing works
Heart Disease and Stroke Statistics—2017 Update: A Report From the American Heart Association
Benjamin, E. J., Blaha, M. J., Chiuve, S. E., Cushman, M., Das, S. R., Deo, R., de Ferranti, S. D., Floyd, J., Fornage, M., Gillespie, C., et al. (2017) · Circulation · doi:10.1161/cir.0000000000000485 · Cited by 12,591 · see citing works
Heart Disease and Stroke Statistics—2019 Update: A Report From the American Heart Association
Benjamin, E. J., Muntner, P., Alonso, A., Bittencourt, M. S., Callaway, C. W., Carson, A. P., Chamberlain, A. M., Chang, A. R., Cheng, S., Das, S. R., et al. (2019) · Circulation · doi:10.1161/cir.0000000000000659 · Cited by 9,036 · see citing works
Heart disease and stroke statistics-2018 update: a report from the american heart association
Benjamin, E. J., Virani, S. S., Callaway, C. W., Chamberlain, A. M., Chang, A. R., Cheng, S., Chiuve, S. E., Cushman, M., Delling, F. N., Deo, R., et al. (2018) · Circulation · doi:10.1161/cir.0000000000000558 · Cited by 7,146 · see citing works
Metabolic Endotoxemia Initiates Obesity and Insulin Resistance
Cani, P. D., Amar, J., Iglesias, M. A., Poggi, M., Knauf, C., Bastelica, D., Neyrinck, A. M., Fava, F., Tuohy, K. M., Chabo, C., et al. (2007) · Diabetes · doi:10.2337/db06-1491 · Cited by 6,638 · see citing works
Diagnosis and classification of diabetes mellitus
American Diabetes Association (2010) · Diabetes Care · doi:10.2337/dc10-s062 · Cited by 5,491 · see citing works
Progress and challenges in translating the biology of atherosclerosis
Libby, P., Ridker, P. M., & Hansson, G. K. (2011) · Nature · doi:10.1038/nature10146 · Cited by 4,010 · see citing works
The Global Epidemic of the Metabolic Syndrome
Saklayen, M. G. (2018) · Current Hypertension Reports · doi:10.1007/s11906-018-0812-z · Cited by 3,990 · see citing works
Chalasani, N., Younossi, Z. M., Lavine, J. E., Diehl, A. M., Brunt, E. M., Cusi, K. J., Charlton, M., & Sanyal, A. J. (2012) · Hepatology · doi:10.1002/hep.25762 · Cited by 3,805 · see citing works
Watterson, K. R., Bestow, D., Gallagher, J. R., Hamilton, D. L., Ashford, F. B., Meakin, P. J., & Ashford, M. L. J. (2012) · Neurosignals · doi:10.1159/000334144 · Cited by 3,395 · see citing works
Pfeffer, M. A., & D, E. B. M. (1990) · Circulation · doi:10.1161/01.cir.81.4.1161 · Cited by 2,873 · see citing works
Diabetes Mellitus, Fasting Glucose, and Risk of Cause-Specific Death
The Emerging Risk Factors Collaboration (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1008862 · Cited by 2,726 · see citing works
Mechanisms underlying the resistance to diet-induced obesity in germ-free mice
Bäckhed, F., Manchester, J. K., Semenkovich, C. F., & Gordon, J. I. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605374104 · Cited by 2,615 · see citing works
Macrophages in atherosclerosis: a dynamic balance
Moore, K. J., Sheedy, F. J., & Fisher, E. A. (2013) · Nature reviews. Immunology · doi:10.1038/nri3520 · Cited by 2,559 · see citing works
Guidelines for the Early Management of Adults With Ischemic Stroke
Adams, H. P., del Zoppo, G., Alberts, M. J., Bhatt, D. L., Brass, L. M., Furlan, A. J., Grubb, R. L., Higashida, R. T., Jauch, E. C., Kidwell, C. S., et al. (2007) · Stroke · doi:10.1161/strokeaha.107.181486 · Cited by 2,461 · see citing works
Mechanisms of plaque formation and rupture
Bentzon, J. F., Otsuka, F., Virmani, R., & Falk, E. (2014) · Circulation Research · doi:10.1161/circresaha.114.302721 · Cited by 2,391 · see citing works
Human Fatty Liver Disease: Old Questions and New Insights
Cohen, J. C., Horton, J. D., & Hobbs, H. H. (2011) · Science · doi:10.1126/science.1204265 · Cited by 2,089 · see citing works
Jung, U. J., & Choi, M. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms15046184 · Cited by 1,898 · see citing works
Diagnosis and classification of diabetes mellitus
American Diabetes Association (2009) · Diabetes Care · doi:10.2337/dc09-s062 · Cited by 1,817 · see citing works
Medicinal plants of India with anti-diabetic potential
Grover, J. K., Yadav, S., & Vats, V. (2002) · Journal of Ethnopharmacology · doi:10.1016/s0378-8741(02)00059-4 · Cited by 1,798 · see citing works
Li, Y., Xu, S., Mihaylova, M. M., Zheng, B., Hou, X., Jiang, B., Park, O., Luo, Z., Lefai, É., Shyy, J. Y.-J., et al. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.03.009 · Cited by 1,788 · see citing works
Self-citationIntestinal permeability – a new target for disease prevention and therapy
Bischoff, S. C., Barbara, G., Buurman, W., Ockhuizen, T., Schulzke, J.-D., Serino, M., Tilg, H., Watson, A., & Wells, J. M. (2014) · BMC Gastroenterology · doi:10.1186/s12876-014-0189-7 · Cited by 1,755 · see citing works
PPARs and the complex journey to obesity
Evans, R. M., Barish, G. D., & Wang, Y.-X. (2004) · Nature Medicine · doi:10.1038/nm1025 · Cited by 1,621 · see citing works
hERG potassium channels and cardiac arrhythmia
Sanguinetti, M. C., & Tristani‐Firouzi, M. (2006) · Nature · doi:10.1038/nature04710 · Cited by 1,582 · see citing works
Kong, W., Wei, J., Abidi, P., Lin, M., Inaba, S., Li, C., Wang, Y., Wang, Z., Si, S., Pan, H., et al. (2004) · Nature Medicine · doi:10.1038/nm1135 · Cited by 1,391 · see citing works
AMP-Activated Protein Kinase in Metabolic Control and Insulin Signaling
Towler, M. C., & Hardie, D. G. (2007) · Circulation Research · doi:10.1161/01.res.0000256090.42690.05 · Cited by 1,247 · see citing works
Purushotham, A., Schug, T. T., Xu, Q., Surapureddi, S., Guo, X., & Li, X. (2009) · Cell Metabolism · doi:10.1016/j.cmet.2009.02.006 · Cited by 1,112 · see citing works
Lee, Y. S., Kim, W. S., Kim, K. H., Yoon, M. J., Cho, H. J., Shen, Y., Ye, J.-M., Lee, C. H., Oh, W. K., Kim, C. T., et al. (2006) · Diabetes · doi:10.2337/db06-0006 · Cited by 1,054 · see citing works
European Society of Cardiology: Cardiovascular Disease Statistics 2019
Timmis, A., Townsend, N. P., Gale, C. P., Torbica, A., Lettino, M., Petersen, S. E., Mossialos, E. A., Maggioni, A. P., Kazakiewicz, D., May, H. T., et al. (2019) · European Heart Journal · doi:10.1093/eurheartj/ehz859 · Cited by 1,035 · see citing works
Michelotti, G. A., Machado, M. V., & Diehl, A. M. (2013) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2013.183 · Cited by 974 · see citing works
European Society of Cardiology: Cardiovascular Disease Statistics 2017
Timmis, A., Petersen, S. E., Belle, E. V., Townsend, N. P., Conrad, N., Kaplon-Cieslicka, A., Kazakiewicz, D., Kavousi, M., Cvijić, M., Ignatiuk, B., et al. (2017) · European Heart Journal · doi:10.1093/eurheartj/ehag345 · Cited by 964 · see citing works
Metabolic Syndrome and Insulin Resistance: Underlying Causes and Modification by Exercise Training
Roberts, C. K., Hevener, A. L., & Barnard, R. J. (2012) · Comprehensive physiology · doi:10.1002/cphy.c110062 · Cited by 919 · see citing works
Guidelines for the Early Management of Adults With Ischemic Stroke
Adams, H. P., del Zoppo, G., Alberts, M. J., Bhatt, D. L., Brass, L. M., Furlan, A. J., Grubb, R. L., Higashida, R. T., Jauch, E. C., Kidwell, C. S., et al. (2007) · Circulation · doi:10.1161/circulationaha.107.181486 · Cited by 901 · see citing works
AMP-Activated Protein Kinase (AMPK) Controls the Aging Process via an Integrated Signaling Network
Salminen, A., & Kaarniranta, K. (2012) · Ageing Research Reviews · doi:10.1016/j.arr.2011.12.005 · Cited by 860 · see citing works
Molecular Basis of Cardioprotection
Heusch, G. (2015) · Circulation Research · doi:10.1161/circresaha.116.305348 · Cited by 811 · see citing works
Efficacy of berberine in patients with type 2 diabetes mellitus
Yin, J., Xing, H., & Ye, J. (2008) · Metabolism · doi:10.1016/j.metabol.2008.01.013 · Cited by 801 · see citing works
The role of fructose in the pathogenesis of NAFLD and the metabolic syndrome
Lim, J. S., Mietus-Snyder, M., Valente, A., Schwarz, J.-M., & Lustig, R. H. (2010) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2010.41 · Cited by 771 · see citing works
Alexander, M. R., & Owens, G. K. (2011) · Annual Review of Physiology · doi:10.1146/annurev-physiol-012110-142315 · Cited by 771 · see citing works
Left Ventricular Remodeling in Heart Failure
Konstam, M. A., Kramer, D. G., Patel, A. R., Maron, M. S., & Udelson, J. E. (2011) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2010.10.008 · Cited by 770 · see citing works
An opportunistic pathogen isolated from the gut of an obese human causes obesity in germfree mice
Fei, N., & Zhao, L.-P. (2012) · The ISME Journal · doi:10.1038/ismej.2012.153 · Cited by 713 · see citing works
Atherosclerosis and inflammation: overview and updates
Geovanini, G. R., & Libby, P. (2018) · Clinical Science · doi:10.1042/cs20180306 · Cited by 703 · see citing works
Zhang, X., Zhao, Y., Xu, J., Xue, Z., Zhang, M., Pang, X., Zhang, X., & Zhao, L. (2015) · Scientific Reports · doi:10.1038/srep14405 · Cited by 630 · see citing works
Zhang, X., Zhao, Y., Zhang, M., Pang, X., Xu, J., Kang, C., Li, M., Zhang, C., Zhang, Z., Zhang, Y., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0042529 · Cited by 615 · see citing works
α-Amylase Inhibitors: A Review of Raw Material and Isolated Compounds from Plant Source
de Sales, P. M., Souza, P. M., Simeoni, L. A., Magalhães, P. O., & Silveira, D. (2012) · Journal of Pharmacy & Pharmaceutical Sciences · doi:10.18433/j35s3k · Cited by 607 · see citing works
Treatment of Type 2 Diabetes and Dyslipidemia with the Natural Plant Alkaloid Berberine
Zhang, Y., Li, X., Zou, D., Liu, W., Yang, J., Zhu, N., Huo, L., Wang, M., Hong, J., Wu, P., et al. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-2404 · Cited by 573 · cited 12× · see citing works
“These ongoing or completed clinical trials are summarized in Supplementary Table 1 (in supplemental material) [23, 112, 325, 351-364].”
BackgroundMethodInfluentialTurner, N., Li, J.-Y., Gosby, A., To, S. W. C., Cheng, Z., Miyoshi, H., Taketo, M. M., Cooney, G. J., Kraegen, E. W., James, D. E., et al. (2008) · Diabetes · doi:10.2337/db07-1552 · Cited by 535 · see citing works
Current knowledge and pharmacological profile of berberine: An update
Kumar, A., Ekavali, Chopra, K., Mukherjee, M., Pottabathini, R., & Dhull, D. K. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.05.068 · Cited by 533 · see citing works
Uyeda, K., & Repa, J. J. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.06.008 · Cited by 531 · see citing works
The metabolism of berberine and its contribution to the pharmacological effects
Wang, K., Feng, X., Chai, L., Cao, S., & Qiu, F. (2017) · Drug Metabolism Reviews · doi:10.1080/03602532.2017.1306544 · Cited by 505 · see citing works
Self-citationKukidome, D., Nishikawa, T., Sonoda, K., Imoto, K., Fujisawa, K., Yano, M., Motoshima, H., Taguchi, T., Matsumura, T., & Araki, E. (2006) · Diabetes · doi:10.2337/diabetes.55.01.06.db05-0943 · Cited by 504 · see citing works
Oxidized LDL: Diversity, Patterns of Recognition, and Pathophysiology
Levitan, I., Volkov, S., & Subbaiah, P. V. (2009) · Antioxidants and Redox Signaling · doi:10.1089/ars.2009.2733 · Cited by 473 · see citing works
Insulin resistance, inflammation, and non-alcoholic fatty liver disease
Tilg, H., & Moschen, A. R. (2008) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2008.08.005 · Cited by 470 · see citing works
Berberine suppresses proinflammatory responses through AMPK activation in macrophages
Jeong, H. W., Hsu, K. C., Lee, J.-W., Ham, M., Huh, J. Y., Shin, H. J., Kim, W. S., & Kim, J. B. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90599.2008 · Cited by 454 · see citing works
Zhang, H., Wei, J., Xue, R., Wu, J.-D., Zhao, W., Wang, Z., Wang, S., Zhou, Z.-X., Song, D., Wang, Y., et al. (2009) · Metabolism · doi:10.1016/j.metabol.2009.07.029 · Cited by 442 · see citing works
Inflammation and endothelial dysfunction during aging: role of NF-κB
Csiszar, A., Wang, M., Lakatta, E. G., & Ungvari, Z. (2008) · Journal of Applied Physiology · doi:10.1152/japplphysiol.90470.2008 · Cited by 441 · see citing works
Role of inflammation in the pathogenesis of atherosclerosis and therapeutic interventions
Raggi, P., Genest, J. J., Giles, J. T., Rayner, K. J., Dwivedi, G., Beanlands, R. S., & Gupta, M. (2018) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2018.07.014 · Cited by 434 · see citing works
Bodmer, M., Meier, C., Krähenbühl, S., Jick, S. S., & Meier, C. R. (2008) · Diabetes Care · doi:10.2337/dc08-1171 · Cited by 422 · see citing works
Antioxidant and Anti‐Inflammatory Activities of Berberine in the Treatment of Diabetes Mellitus
Li, Z., Geng, Y., Jiang, J., & Kong, W. (2014) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2014/289264 · Cited by 385 · see citing works
Chen, W., Miao, Y.-Q., Fan, D.-J., Yang, S.-S., Lin, X., Meng, L.-K., & Tang, X. (2011) · AAPS PharmSciTech · doi:10.1208/s12249-011-9632-z · Cited by 363 · see citing works
Research progress on berberine with a special focus on its oral bioavailability
Liu, C.-S., Zheng, Y.-R., Zhang, Y.-F., & Long, X.-Y. (2016) · Fitoterapia · doi:10.1016/j.fitote.2016.02.001 · Cited by 363 · see citing works
Berberis Vulgaris and Berberine: An Update Review
Imenshahidi, M., & Hosseinzadeh, H. (2016) · Phytotherapy Research · doi:10.1002/ptr.5693 · Cited by 363 · see citing works
Li, H., Dong, B., Park, S. W., Lee, H.-S., Chen, W., & Liu, J. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.052407 · Cited by 349 · see citing works
Current concepts in the pathogenesis of abdominal aortic aneurysm
Ailawadi, G., Eliason, J. L., & Upchurch, G. R. (2003) · Journal of Vascular Surgery · doi:10.1016/s0741-5214(03)00324-0 · Cited by 339 · see citing works
In Vitro Antioxidant Studies on the Benzyl Tetra Isoquinoline Alkaloid Berberine
Shirwaikar, A., Shirwaikar, A., Rajendran, K., & Samraj, P. I. (2006) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.29.1906 · Cited by 330 · see citing works
SREBPs suppress IRS-2-mediated insulin signalling in the liver
Ide, T., Shimano, H., Yahagi, N., Matsuzaka, T., Nakakuki, M., Yamamoto, T., Nakagawa, Y., Takahashi, A., Suzuki, H., Sone, H., et al. (2004) · Nature Cell Biology · doi:10.1038/ncb1111 · Cited by 321 · see citing works
Berberine: a potential phytochemical with multispectrum therapeutic activities
Vuddanda, P. R., Chakraborty, S., & Singh, S. (2010) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2010.517745 · Cited by 317 · see citing works
Transforming berberine into its intestine-absorbable form by the gut microbiota
Feng, R., Shou, J.-W., Zhao, Z.-X., He, C.-Y., Ma, C., Huang, M., Fu, J., Tan, X.-S., Li, X.-Y., Wen, B.-Y., et al. (2015) · Scientific Reports · doi:10.1038/srep12155 · Cited by 307 · see citing works
Diabetes is an inflammatory disease: evidence from traditional Chinese medicines
Xie, W., & Du, L. (2010) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2010.01336.x · Cited by 305 · see citing works
LOX-1 in atherosclerosis: biological functions and pharmacological modifiers
Xu, S., Ogura, S., Chen, J., Little, P. J., Moss, J., & Liu, P. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-1194-z · Cited by 293 · see citing works
Self-citationCardiovascular actions of berberine
Lau, C., Yao, X., Chen, Z., Ko, W., & Huang, Y. (2001) · Cardiovascular Drug Reviews · doi:10.1111/j.1527-3466.2001.tb00068.x · Cited by 281 · see citing works
Berberine inhibits 3T3-L1 adipocyte differentiation through the PPARγ pathway
Huang, C., Zhang, Y., Gong, Z., Sheng, X., Li, Z., Zhang, W., & Qin, Y. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.07.095 · Cited by 277 · see citing works
PPARs and nonalcoholic fatty liver disease
Liss, K. H. H., & Finck, B. N. (2016) · Biochimie · doi:10.1016/j.biochi.2016.11.009 · Cited by 275 · see citing works
The Role of Nutraceuticals in Statin Intolerant Patients
Banach, M., Patti, A. M., Giglio, R. V., Cicero, A. F. G., Atanasov, A. G., Bajraktari, G., Bruckert, E., Descamps, O., Djuric, D. M., Ezhov, M., et al. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.04.040 · Cited by 272 · see citing works
Tissue Distribution of Berberine and Its Metabolites after Oral Administration in Rats
Tan, X.-S., Ma, J.-Y., Feng, R., Ma, C., Chen, W.-J., Sun, Y.-P., Fu, J., Huang, M., He, C.-Y., Shou, J.-W., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0077969 · Cited by 266 · see citing works
Kong, W., Zhang, H., Song, D., Xue, R., Zhao, W., Wei, J., Wang, Y., Shan, N., Zhou, Z., Yang, P., et al. (2008) · Metabolism · doi:10.1016/j.metabol.2008.08.013 · Cited by 266 · see citing works
Berberine Improves Glucose Metabolism in Diabetic Rats by Inhibition of Hepatic Gluconeogenesis
Xia, X., Yan, J., Shen, Y., Tang, K., Yin, J., Zhang, Y., Yang, D., Liang, H., Ye, J., & Weng, J. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016556 · Cited by 262 · see citing works
Battu, S. K., Repka, M. A., Maddineni, S., Chittiboyina, A. G., Avery, M. A., & Majumdar, S. (2010) · AAPS PharmSciTech · doi:10.1208/s12249-010-9520-y · Cited by 261 · see citing works
Endothelium‐dependent contractions and endothelial dysfunction in human hypertension
Versari, D., Daghini, E., Virdis, A., Ghiadoni, L., & Taddei, S. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00240.x · Cited by 255 · see citing works
Eid, A. A., Ford, B. M., Block, K. L., Kasinath, B. S., Gorin, Y. C., Ghosh-Choudhury, G., Barnes, J. L., & Abboud, H. E. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.136796 · Cited by 255 · see citing works
El-Wahab, A. E. A., Ghareeb, D. A., Sarhan, E. M., Abu-Serie, M. M., & Demellawy, M. E. (2013) · BMC Complementary and Alternative Medicine · doi:10.1186/1472-6882-13-218 · Cited by 250 · see citing works
Méndez-del Villar, M., González-Ortiz, M., Martínez-Abundis, E., Pérez-Rubio, K. G., & Lizárraga-Valdez, R. (2014) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2014.0082 · Cited by 246 · see citing works
Chinese Journal of Integrated Traditional and Western Medicine
Wu, W. Q. (1996) · JAMA · doi:10.1001/jama.1996.03530340073041 · Cited by 246 · see citing works
Insulin Resistance: Metabolic Mechanisms and Consequences in the Heart
Abel, E. D., O’Shea, K. M., & Ramasamy, R. (2012) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.111.241984 · Cited by 244 · see citing works
Zhu, L., Zhang, D., Zhu, H., Zhu, J., Weng, S., Dong, L., Liu, T., Hu, Y., & Shen, X. (2017) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2017.11.023 · Cited by 243 · see citing works
Kim, W. S., Lee, Y. S., Cha, S. H., Jeong, H. W., Choe, S. S., Lee, M., Oh, G. T., Park, H., Lee, K., Lane, M. D., et al. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90710.2008 · Cited by 239 · see citing works
Efficacy of Berberine in Patients with Non-Alcoholic Fatty Liver Disease
Yan, H., Xia, M., Wang, Y., Chang, X., Yao, X., Rao, S., Zeng, M., Tu, Y., Feng, R., Jia, W., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0134172 · Cited by 233 · see citing works
Berberine decreases PCSK9 expression in HepG2 cells
Cameron, J., Ranheim, T., Kulseth, M. A., Leren, T. P., & Berge, K. E. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2008.02.004 · Cited by 232 · see citing works
Insulin Resistance: Cellular and Clinical Concepts
Cefalu, W. T. (2001) · Experimental Biology and Medicine · doi:10.1177/153537020122600103 · Cited by 230 · see citing works
The involvement of P-glycoprotein in berberine absorption
Pan, G., Wang, G., Liu, X., Fawcett, J. P., & Xie, Y. (2002) · Pharmacology & Toxicology · doi:10.1034/j.1600-0773.2002.t01-1-910403.x · Cited by 225 · see citing works
On the mechanism of antidepressant-like action of berberine chloride
Kulkarni, S. K., & Dhir, A. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.05.043 · Cited by 223 · see citing works
Nano strategies for berberine delivery, a natural alkaloid of Berberis
Mirhadi, E., Rezaee, M., & Malaekeh‐Nikouei, B. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.05.067 · Cited by 219 · see citing works
Endothelial progenitor cells: novel biomarker and promising cell therapy for cardiovascular disease
Sen, S., McDonald, S. P., Coates, P. T., & Bonder, C. S. (2010) · Clinical Science · doi:10.1042/cs20100429 · Cited by 211 · see citing works
Berberine-induced bioactive metabolites of the gut microbiota improve energy metabolism
Wang, Y., Shou, J., Li, X., Zhao, Z., Fu, J., He, C., Feng, R., Ma, C., Wen, B., Guo, F., et al. (2017) · Metabolism · doi:10.1016/j.metabol.2017.02.003 · Cited by 206 · see citing works
Sun, R., Yang, N., Kong, B., Cao, B., Feng, D., Yu, X., Ge, C., Huang, J., Shen, J., Wang, P., et al. (2017) · Molecular Pharmacology · doi:10.1124/mol.116.106617 · Cited by 199 · see citing works
Clinical Evidence of Herbal Drugs As Perpetrators of Pharmacokinetic Drug Interactions
Hermann, R., & von Richter, O. (2012) · Planta Medica · doi:10.1055/s-0032-1315117 · Cited by 197 · see citing works
Zeng, X., Zeng, X., & Li, Y.-Y. (2003) · The American Journal of Cardiology · doi:10.1016/s0002-9149(03)00533-2 · Cited by 192 · see citing works
Hua, W., Ding, L., Chen, Y., Gong, B., He, J., & Xu, G. (2007) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2007.03.022 · Cited by 192 · see citing works
Phenotypic Modulation of Vascular Smooth Muscle Cells Induced by Unsaturated Lysophosphatidic Acids
Hayashi, K., Takahashi, M. P., Nishida, W., et al. (2001) · Circulation Research · doi:10.1161/hh1501.094265 · Cited by 192 · see citing works
Domitrović, R., Cvijanović, O., Pugel, E. P., Škoda, M., Mikelić, L., & Crnčević-Orlić, Ž. (2013) · Food and Chemical Toxicology · doi:10.1016/j.fct.2013.09.003 · Cited by 191 · see citing works
Gu, Y., Zhang, Y., Shi, X., Li, X., Hong, J., Chen, J., Gu, W., Lu, X., Xu, G., & Ning, G. (2010) · Talanta · doi:10.1016/j.talanta.2010.01.015 · Cited by 190 · see citing works
Ma, X., Chen, Z., Wang, L., Wang, G., Wang, Z., Dong, X., Wen, B., & Zhang, Z. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00782 · Cited by 189 · see citing works
Fan, X., Wang, J., Hou, J., Lin, C.-R., Bensoussan, A., Chang, D., Liu, J., & Wang, B. (2015) · Journal of Translational Medicine · doi:10.1186/s12967-015-0450-z · Cited by 185 · see citing works
Xie, W., Gu, D., Li, J., Cui, K., & Zhang, Y. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024520 · Cited by 183 · see citing works
Effects and mechanisms of berberine in diabetes treatment
Yin, J., Ye, J., & Jia, W. (2012) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2012.06.003 · Cited by 183 · see citing works
Intestinal microbiota and type 2 diabetes: From mechanism insights to therapeutic perspective
Han, J.-L., & Lin, H. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i47.17737 · Cited by 179 · see citing works
Reactive Oxygen Species Generation and Atherosclerosis
Nowak, W. N., Deng, J., Ruan, X. Z., & Xu, Q. (2017) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.117.309228 · Cited by 179 · see citing works
Abidi, P., Zhou, Y., Jiang, J., & Liu, J. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000181761.16341.2b · Cited by 176 · see citing works
Targeting epigenetics and non-coding RNAs in atherosclerosis: from mechanisms to therapeutics
Xu, S., Kamato, D., Little, P. J., Nakagawa, S., Pelisek, J., & Jin, Z. G. (2018) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.11.003 · Cited by 176 · see citing works
Self-citationPharmacological effects of berberine and its derivatives: a patent update
Jin, Y., Khadka, D. B., & Cho, W. (2015) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.2016.1118060 · Cited by 174 · see citing works
Neuroprotective effects of berberine on stroke models in vitro and in vivo
Zhou, X., Zeng, X., Kong, H., & Sun, X. (2008) · Neuroscience Letters · doi:10.1016/j.neulet.2008.09.064 · Cited by 173 · see citing works
Xu, S., Huang, Y., Xie, Y., Lan, T., Le, K., Chen, J., Chen, S., Gao, S., Xu, X.-Z., Shen, X., et al. (2010) · Cytotechnology · doi:10.1007/s10616-010-9290-0 · Cited by 172 · see citing works
Self-citationJhong, C., Riyaphan, J., Lin, S., Chia, Y., & Weng, C. (2015) · BioFactors · doi:10.1002/biof.1219 · Cited by 171 · see citing works
Dong, H., Zhao, Y., Zhao, L., & Lu, F. (2013) · Planta Medica · doi:10.1055/s-0032-1328321 · Cited by 171 · see citing works
Chen, K., Li, G., Geng, F., Zhang, Z., Li, J., Yang, M. H., Dong, L., & Gao, F. (2014) · APOPTOSIS · doi:10.1007/s10495-014-0977-0 · Cited by 168 · see citing works
Li, W., Suwanwela, N. C., & Patumraj, S. (2015) · Microvascular Research · doi:10.1016/j.mvr.2015.12.008 · Cited by 166 · see citing works
Wang, Y., Huang, Y., Lam, K. S. L., Li, Y., Wong, W. T., Ye, H., Lau, C., Vanhoutte, P. M., & Xu, A. (2009) · Cardiovascular Research · doi:10.1093/cvr/cvp078 · Cited by 165 · see citing works
Combination of simvastatin with berberine improves the lipid-lowering efficacy
Kong, W., Wei, J., Zuo, Z.-Y., Wang, Y., Song, D., You, X., Zhao, L., Pan, H.-N., & Jiang, J. (2008) · Metabolism · doi:10.1016/j.metabol.2008.01.037 · Cited by 162 · see citing works
Zhao, G., Yu, L., Gao, W., Duan, W., Jiang, B., Liu, X., Zhang, B., Liu, Z., Zhai, M., Jin, Z., et al. (2016) · Acta Pharmacologica Sinica · doi:10.1038/aps.2015.136 · Cited by 162 · see citing works
Atherosclerosis Is an Epigenetic Disease
Xu, S., Pelisek, J., & Jin, Z. G. (2018) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2018.04.007 · Cited by 161 · see citing works
Self-citationChang, W., Chen, L., & Hatch, G. M. (2014) · Biochemistry and Cell Biology · doi:10.1139/bcb-2014-0107 · Cited by 159 · see citing works
Dong, B., Li, H., Singh, A. B., Cao, A., & Liu, J. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.597229 · Cited by 158 · see citing works
Chang, X., Yan, H., Jing, F., Jiang, M., Zhu, H., Lu, D., & Gao, X. (2010) · Journal of Lipid Research · doi:10.1194/jlr.m001958 · Cited by 157 · see citing works
Li, C., Tan, L., Wang, Y.-F., Luo, C., Chen, H., Lü, Q., Li, Y., Yang, X., Chen, J., Liu, Y., et al. (2018) · Phytomedicine · doi:10.1016/j.phymed.2018.09.228 · Cited by 157 · see citing works
Wei, W., Zhao, H., Wang, A., Sui, M., Liang, K., Deng, H., Ma, Y., Zhang, Y., Zhang, H., & Guan, Y. (2012) · European Journal of Endocrinology · doi:10.1530/eje-11-0616 · Cited by 155 · see citing works
Feng, W., Wang, H., Zhang, P., Gao, C., Tao, J., Ge, Z., Zhu, D., & Bi, Y. (2017) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2017.03.017 · Cited by 155 · see citing works
Perioperative beta-blockers for preventing surgery-related mortality and morbidity
Blessberger, H., Kammler, J., Domanovits, H., Schlager, O., Wildner, B., Azar, D., Schillinger, M., Wiesbauer, F., & Steinwender, C. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004476.pub2 · Cited by 153 · see citing works
Segmental Aortic Stiffening Contributes to Experimental Abdominal Aortic Aneurysm Development
Raaz, U., Zöllner, A. M., Schellinger, I. N., et al. (2015) · Circulation · doi:10.1161/circulationaha.114.012377 · Cited by 152 · see citing works
Huang, Z., Han, Z., Ye, B., Dai, Z., Shan, P., Lu, Z., Dai, K., Wang, C., & Huang, W. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.05.028 · Cited by 151 · see citing works
Sommer, F., Adam, N., Johansson, M., Xia, L., Hansson, G. C., & Bäckhed, F. (2014) · PLoS ONE · doi:10.1371/journal.pone.0085254 · Cited by 150 · see citing works
Sun, Y., Xia, M., Yan, H., Han, Y., Zhang, F., Hu, Z., Cui, A., Ma, F., Liu, Z., Gong, Q., et al. (2017) · British Journal of Pharmacology · doi:10.1111/bph.14079 · Cited by 150 · see citing works
Wang, X., Wang, R., Xing, D., et al. (2005) · Life Sciences · doi:10.1016/j.lfs.2005.02.033 · Cited by 148 · see citing works
Wang, Q., Zhang, M., Liang, B., Shirwany, N. A., Zhu, Y., & Zou, M. (2011) · PLoS ONE · doi:10.1371/journal.pone.0025436 · Cited by 144 · see citing works
Jiang, Q. L., Liu, P., Wu, X., Liu, W., Shen, X., Lan, T., Xu, S., Peng, J., Xie, X. S., & Huang, H. (2010) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2010.07.023 · Cited by 144 · see citing works
Self-citationZhu, J., Lu, H.-D., Guo, C., Fang, W., Zhao, H.-D., Zhou, J., Wang, F., Zhao, Y., Li, Y., Zhang, Y., et al. (2018) · Acta Pharmacologica Sinica · doi:10.1038/s41401-018-0160-1 · Cited by 144 · see citing works
Xu, Z., Feng, W., Shen, Q., Yu, N., Yu, K., Wang, S., Chen, Z., Shioda, S., & Guo, Y. (2017) · Aging and Disease · doi:10.14336/ad.2016.0620 · Cited by 143 · see citing works
Janbaz, K. H., & Gilani, A. H. (2000) · Fitoterapia · doi:10.1016/s0367-326x(99)00098-2 · Cited by 141 · see citing works
Clopidogrel plus aspirin versus aspirin alone for preventing cardiovascular events
Squizzato, A., Bellesini, M., Takeda, A., Middeldorp, S., & Donadini, M. P. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005158.pub4 · Cited by 141 · see citing works
Modulating gut microbiota as an anti-diabetic mechanism of berberine
Han, J.-L., Lin, H., & Huang, W. (2011) · Medical Science Monitor · doi:10.12659/msm.881842 · Cited by 140 · see citing works
Natural approaches in metabolic syndrome management
Patti, A. M., Al‐Rasadi, K., Giglio, R. V., Nikolić, D., Mannina, C. M., Castellino, G., Chianetta, R., Banach, M., Cicero, A. F. G., Lippi, G., et al. (2017) · Archives of Medical Science · doi:10.5114/aoms.2017.68717 · Cited by 139 · see citing works
Repeated administration of berberine inhibits cytochromes P450 in humans
Guo, Y., Chen, Y., Tan, Z.-R., Klaassen, C. D., & Zhou, H.-H. (2012) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-011-1108-2 · Cited by 137 · see citing works
Lipid-lowering effect of berberine in human subjects and rats
Hu, Y., Ehli, E. A., Kittelsrud, J. M., Ronan, P. J., Munger, K. A., Downey, T., Bohlen, K., Callahan, L. B., Munson, V., Jahnke, M., et al. (2012) · Phytomedicine · doi:10.1016/j.phymed.2012.05.009 · Cited by 136 · see citing works
Berberine Modulates Gut Microbiota and Reduces Insulin Resistance via the TLR4 Signaling Pathway
Liu, D., Zhang, Y., Liu, Y., Hou, L.-Q., Li, S., Tian, H., & Zhao, T.-Y. (2018) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-0043-125066 · Cited by 136 · see citing works
Affuso, F., Ruvolo, A., Micillo, F., Saccà, L., & Fazio, S. (2009) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2009.05.017 · Cited by 135 · see citing works
Palanivel, C., Gowrikumar, S., Manikandan, R., & Sudhandiran, G. (2013) · Toxicology Letters · doi:10.1016/j.toxlet.2013.03.009 · Cited by 133 · see citing works
Berberine alleviates insulin resistance by reducing peripheral branched-chain amino acids
Yue, S., Liu, J., Wang, A.-T., Meng, X., Yang, Z.-R., Peng, C. Y., Guan, H., Wang, C., & Yan, D. (2018) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00256.2018 · Cited by 130 · see citing works
Cardiovascular effects of berberine in patients with severe congestive heart failure
Marin ‐ NETO, J. A., Maciel, B. C., Secches, A. L., & Gallo, L. (1988) · Clinical Cardiology · doi:10.1002/clc.4960110411 · Cited by 128 · see citing works
P-glycoprotein-mediated transport of berberine across Caco-2 cell monolayers
Maeng, H.-J., Yoo, H.-J., Kim, I.-W., Song, I.-S., Chung, S.-J., & Shim, C.-K. (2002) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.10268 · Cited by 128 · see citing works
Endothelial Function and Dysfunction: Impact of Metformin
Nafisa, A., Gray, S. G., Cao, Y., Wang, T., Xu, S., Wattoo, F. H., Barras, M., Cohen, N., Kamato, D., & Little, P. J. (2018) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.07.007 · Cited by 128 · see citing works
Berberine inhibits adipogenesis in high-fat diet-induced obesity mice
Hu, Y., & Davies, G. E. (2009) · Fitoterapia · doi:10.1016/j.fitote.2009.10.010 · Cited by 127 · see citing works
Ju, J., Li, J., Lin, Q., & Xu, H. (2018) · Phytomedicine · doi:10.1016/j.phymed.2018.09.212 · Cited by 124 · see citing works
Modulation of glucagon-like peptide-1 release by berberine: In vivo and in vitro studies
Yu, Y., Liu, L., Wang, X., Liu, X., Liu, X., Xie, L. Y., & Wang, G. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.11.017 · Cited by 123 · see citing works
PPARs and the complex journey to obesity
Evans, R. M. (2004) · The Keio Journal of Medicine · doi:10.2302/kjm.53.53 · Cited by 123 · see citing works
Yu, L., Li, Q., Yu, B., Yang, Y., Jin, Z., Duan, W., Zhao, G., Zhai, M., Liu, L., Yi, D., et al. (2015) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/1689602 · Cited by 122 · see citing works
Atheroprotective Effects and Molecular Targets of Tanshinones Derived From Herbal Medicine Danshen
Fang, J., Little, P. J., & Xu, S. (2017) · Medicinal Research Reviews · doi:10.1002/med.21438 · Cited by 122 · see citing works
Self-citationMetformin and berberine, two versatile drugs in treatment of common metabolic diseases
Wang, H., Zhu, C., Ying, Y., Luo, L., Huang, D., & Luo, Z. (2017) · Oncotarget · doi:10.18632/oncotarget.20807 · Cited by 122 · see citing works
Vasorelaxant and antiproliferative effects of berberine
Ko, W. H., Yao, X., Lau, C., Law, W.-I., Chen, Z., Kwok, W., Ho, W. K. K., & Huang, Y. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00339-3 · Cited by 121 · see citing works
AMPK in cardiac fibrosis and repair: Actions beyond metabolic regulation
Daskalopoulos, E. P., Dufeys, C., Bertrand, L., Beauloye, C., & Horman, S. (2016) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2016.01.001 · Cited by 119 · see citing works
Li, M., Zhang, Y., Yu, Y., Yang, S., Iqbal, J., Mi, Q., Li, B., Wang, Z., Mao, W., Xie, H., et al. (2014) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2014.01.061 · Cited by 118 · see citing works
Berberine Attenuates Intestinal Mucosal Barrier Dysfunction in Type 2 Diabetic Rats
Gong, J., Hu, M., Huang, Z., Fang, K., Wang, D., Chen, Q., Li, J., Yang, D., Zou, X. G., Xu, L., et al. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00042 · Cited by 116 · see citing works
Cicero, A. F. G., Rovati, L. C., & Setnikar, I. (2011) · Arzneimittelforschung · doi:10.1055/s-0031-1296582 · Cited by 114 · see citing works
Li, M., Shu, X., Xu, H., Zhang, C., Yang, L., Zhang, L. R., & Ji, G. (2016) · Journal of Translational Medicine · doi:10.1186/s12967-016-0987-5 · Cited by 114 · see citing works
Effect of berberine administration on metabolic syndrome, insulin sensitivity, and insulin secretion
Pérez-Rubio, K. G., González-Ortiz, M., Martínez-Abundis, E., Robles-Cervantes, J. A., & Espinel-Bermúdez, M. C. (2013) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2012.0183 · Cited by 113 · see citing works
Germoush, M. O., & Mahmoud, A. M. (2014) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-014-1665-8 · Cited by 112 · see citing works
Effects of berberine on lipid profile in subjects with low cardiovascular risk
Derosa, G., D'Angelo, A., Bonaventura, A., Bianchi, L., Romano, D., & Maffioli, P. (2013) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2013.776037 · Cited by 112 · see citing works
Rhizoma Coptidis: A Potential Cardiovascular Protective Agent
Tan, H., Chan, K., Pusparajah, P., Duangjai, A., Saokaew, S., Khan, T. M., Lee, L., & Goh, B. H. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00362 · Cited by 112 · see citing works
Guo, T., Woo, S., Guo, X., Li, H., Zheng, J., Botchlett, R. E., Liu, M., Pei, Y., Xu, H., Cai, Y., et al. (2016) · Scientific Reports · doi:10.1038/srep22612 · Cited by 111 · see citing works
Berberine treatment reduces atherosclerosis by mediating gut microbiota in apoE-/- mice
Shi, Y., Hu, J., Geng, J., Hu, T., Wang, B., Yan, W., Jiang, Y., Li, J., & Liu, S. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.08.148 · Cited by 111 · see citing works
Fatehi‐Hassanabad, Z., Jafarzadeh, M., Tarhini, A., & Fatehi, M. (2005) · Phytotherapy Research · doi:10.1002/ptr.1661 · Cited by 110 · see citing works
Zhang, X., Zhang, X., Wang, C., Lǐ, Y., Dong, L., Cui, L., Wang, L., Liu, Z., Qiao, H., Zhu, C., et al. (2012) · Brain Research · doi:10.1016/j.brainres.2012.03.065 · Cited by 110 · see citing works
Cheng, F., Wang, Y., Li, J., Su, C., Wu, F., Xia, W., Yang, Z., Yu, B., Qiu, Y., & Tao, J. (2012) · International Journal of Cardiology · doi:10.1016/j.ijcard.2012.03.090 · Cited by 108 · see citing works
Displacement of Bilirubin from Albumin by Berberine
Chan, E. (2009) · Biology of the Neonate · doi:10.1159/000243932 · Cited by 107 · see citing works
Type 1 diabetes, hyperglycaemia, and the heart
Retnakaran, R. R., & Zinman, B. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60767-9 · Cited by 107 · see citing works
Berberine inhibits PTP1B activity and mimics insulin action
Chen, C., Zhang, Y., & Huang, C. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.05.153 · Cited by 106 · see citing works
Berberine: Pathways to protect neurons
Lin, X., & Zhang, N. (2018) · Phytotherapy Research · doi:10.1002/ptr.6107 · Cited by 106 · see citing works
Hsieh, Y., Kuo, W., Lin, T.-W., Chang, H., Lin, T.-H., Chen, P., & Chu, S. (2007) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf071868c · Cited by 103 · see citing works
Wang, C., Li, J., Lv, X., Zhang, M., Song, Y., Chen, L., & Liu, Y. (2009) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2009.07.027 · Cited by 102 · see citing works
Chang, W., Zhang, M., Li, J., Meng, Z., Wei, S., Du, H., Chen, L., & Hatch, G. M. (2013) · Metabolism · doi:10.1016/j.metabol.2013.02.007 · Cited by 102 · see citing works
Zhou, H., Feng, L., Xu, F., Sun, Y., Ma, Y., Zhang, X., Liu, H., Xu, G., Wu, X., Shen, Y., et al. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.03.003 · Cited by 100 · see citing works
Yang, J., Yan, H., Li, S., & Zhang, M. (2018) · Neurochemical Research · doi:10.1007/s11064-018-2472-4 · Cited by 100 · see citing works
Meng, S., Wang, L., Huang, Z., Zhou, Q., Sun, Y., Cao, J., Li, Y., & Wang, C. (2012) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2012.05670.x · Cited by 99 · see citing works
Familial Abdominal Aortic Aneurysm: a Systematic Review of a Genetic Background
Keulen, C. J. V. V.-V., Pals, G., & Rauwerda, H. (2002) · European Journal of Vascular and Endovascular Surgery · doi:10.1053/ejvs.2002.1692 · Cited by 98 · see citing works
Xu, S., Bai, P., Little, P. J., & Liu, P. (2013) · Medicinal Research Reviews · doi:10.1002/med.21300 · Cited by 97 · see citing works
Self-citationTargeting LOX‐1 in atherosclerosis and vasculopathy: current knowledge and future perspectives
Tian, K., Ogura, S., Little, P. J., Xu, S., & Sawamura, T. (2018) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.13984 · Cited by 97 · see citing works
Self-citationKim, Y. M., Ha, Y. M., Jin, Y. C., Shi, L. Y., Lee, Y. S., Kim, H. J., Seo, H. G., Choi, J. S., Kim, Y. S., Kang, S. S., et al. (2009) · Food and Chemical Toxicology · doi:10.1016/j.fct.2009.05.031 · Cited by 96 · see citing works
Berberine Promotes Glucose Consumption Independently of AMP-Activated Protein Kinase Activation
Xu, M., Xiao, Y., Yin, J., Hou, W., Xue-ying, Y., Shen, L., Liu, F., Wei, L., & Jia, W. (2014) · PLoS ONE · doi:10.1371/journal.pone.0103702 · Cited by 96 · see citing works
Chang, X., Wang, Z., Zhang, J., Yan, H., Bian, H., Xia, M., Lin, H., Jiang, J., & Gao, X. (2016) · Journal of Translational Medicine · doi:10.1186/s12967-016-0982-x · Cited by 96 · see citing works
Zhang, H. Y., Piao, X., Zhang, Q., et al. (2013) · Poultry Science · doi:10.3382/ps.2013-03081 · Cited by 95 · see citing works
Yu, L., Li, F., Zhao, G., Yang, Y., Jin, Z., Zhai, M., Yu, W., Zhao, L., Chen, W., Duan, W., et al. (2015) · APOPTOSIS · doi:10.1007/s10495-015-1122-4 · Cited by 94 · see citing works
Cardiovascular and metabolic effects of Berberine
Affuso, F. (2010) · World Journal of Cardiology · doi:10.4330/wjc.v2.i4.71 · Cited by 94 · see citing works
Berberine-sonodynamic therapy induces autophagy and lipid unloading in macrophage
Kou, J., Li, Y., Zhong, Z., Jiang, Y., Li, X. S., Han, X. B., Liu, Z. N., Tian, Y., & Yang, L. M. (2017) · Cell Death and Disease · doi:10.1038/cddis.2016.354 · Cited by 94 · see citing works
Inflammation and atherosclerosis: Cardiovascular evaluation in patients with autoimmune diseases
Escarcega, R. O., Lipinski, M. J., García‐Carrasco, M., Pinto, C. M., Gálvez-Romero, J. L., & Cervera, R. (2018) · Autoimmunity Reviews · doi:10.1016/j.autrev.2018.01.021 · Cited by 93 · see citing works
Berberine improves glucogenesis and lipid metabolism in nonalcoholic fatty liver disease
Zhao, L., Cang, Z., Sun, H., Nie, X., Wang, N., & Lu, Y. (2017) · BMC Endocrine Disorders · doi:10.1186/s12902-017-0165-7 · Cited by 92 · see citing works
Wang, F., Wu, Y. T., Zhu, Y. ‐., Ding, T., Batterham, R. L., Qu, F., & Hardiman, P. J. (2018) · Obesity Reviews · doi:10.1111/obr.12720 · Cited by 92 · see citing works
Liu, L., Liu, J., Huang, Z., Yu, X., Zhang, X., Dou, D., & Huang, Y. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.02.028 · Cited by 90 · see citing works
Sun, H., Wang, N., Cang, Z., Zhu, C., Zhao, L., Nie, X., Cheng, J., Xia, F., Zhai, H., & Lu, Y. (2016) · Obesity Facts · doi:10.1159/000449507 · Cited by 90 · see citing works
Perioperative beta-blockers for preventing surgery-related mortality and morbidity
Blessberger, H., Kammler, J., Domanovits, H., Schlager, O., Wildner, B., Azar, D., Schillinger, M., Wiesbauer, F., & Steinwender, C. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004476.pub3 · Cited by 90 · see citing works
Flagged first, then by citations
Research works printed but not linked: 4
- [49]Halcox JPJ Chapter 66 - Endothelial Dysfunction A2 - Robertson, David Biaggioni I Burnstock G Low PA Paton JFR Primer on the Autonomic Nervous System (Third Edition) San Diego Academic Press 2012 p. 319-24
- [53]Xu S Pelisek J Jin ZG Atherosclerosis Is an Epigenetic Disease Trends Endocrinol Metab 2018 29 739 42 29753613 PMC7202861
- [101]Shah BH Nawaz Z Saeed SA Gilani AHJPR Agonist-dependent differential effects of berberine in human platelet aggregation 2010; 12: S60-S2
- [252]Xiao-Ping Y Chun-Qing S Ping Y Ren-Gang M α-Glucosidase and α-amylase inhibitory activity of common constituents from traditional Chinese medicine used for diabetes mellitus Chinese Journal of Natural Medicines 2010 8 349 52
Cited by
Sorted by citations
Liu, Z., Ma, X., Ilyas, I., Zheng, X., Luo, S., Little, P. J., Kamato, D., Sahebkar, A., Wu, W., Weng, J., et al. (2021) · Theranostics · doi:10.7150/thno.54498 · Cited by 155 · see citing works
Self-citationGuo, J., Chen, H., Zhang, X., Lou, W., Zhang, P., Qiu, Y., Zhang, C., Wang, Y., & Liu, W. J. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/2074610 · Cited by 110 · see citing works
Wu, Y., Chen, Q., Wen, B., Wu, N., He, B., & Chen, J. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.640758 · Cited by 54 · see citing works
Solnier, J., Zhang, Y., Kuo, Y., Du, M., Roh, K., Gahler, R., Wood, S., & Chang, C. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15112567 · Cited by 47 · see citing works
Zamani, M., Zarei, M., Nikbaf-Shandiz, M., Hosseini, S., Shiraseb, F., & Asbaghi, O. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.1013055 · Cited by 28 · see citing works
Cole, L. K., Zhang, M., Chen, L., Sparagna, G. C., Vandel, M., Xiang, B., Dolinsky, V. W., & Hatch, G. M. (2021) · The Journal of Nutrition · doi:10.1093/jn/nxaa408 · Cited by 18 · see citing works
Sex‐Dependent Effects of <scp>CYP2D6</scp> on the Pharmacokinetics of Berberine in Humans
Blöcher, J. A., Meyer‐Tönnies, M. J., Morof, F., Rönnpagel, V., Bethmann, J., Vollmer, M., Engeli, S., & Tzvetkov, M. V. (2025) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.3454 · Cited by 16 · see citing works
- Authors
- Feng, X., Sureda, A., Jafari, S., Memariani, Z., Tewari, D., Annunziata, G., Barrea, L., Hassan, S. T. S., Šmejkal, K., Malaník, M., Sychrová, A., Barreca, D., Ziberna, L., Mahomoodally, M. F., Zengin, G., Xu, S., Nabavi, S. M., & Shen, A.-Z.
- Affiliations
- University of Science and Technology of China (CN)
- Instituto de Salud Carlos III (ES)
- Zanjan University of Medical Sciences (IR)
- Babol University of Medical Sciences (IR)
- Lovely Professional University (IN)
- University of Naples Federico II (IT)
- University of Veterinary Sciences Brno (CZ)
- University of Messina (IT)
- University of Mauritius (MU)
- University of Rochester Medicine (US)
- Baqiyatallah University of Medical Sciences (IR)
- Corresponding author
- Xu, Suowen
- Nabavi, Seyed Mohammad
- Shen, Ai-Zong
- ORCID
- Venue
- Theranostics
- Publisher
- Ivyspring International Publisher
- Published
- 2019
- Volume
- 9
- Issue
- 7
- Pages
- 1923-1951
- ISSN
- 1838-7640 (ISSN-L)
- PMC
- PMC6485276
- OpenAlex
- W2924395156
- Cited by
- 465
- References
- 400
- Citations by year
- 2026: 74 · 2025: 84 · 2024: 70 · 2023: 60 · 2022: 58 · 2021: 63 · 2020: 41 · 2019: 12 · 2018: 2
- FWCI
- 5.56
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-nc
- Locations
- Theranostics (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Docusalut (Conselleria de Salut i Consum del Govern de les Illes Balears) (submittedVersion, cc-by-nc)
- Hispana (submittedVersion, cc-by-nc)
- Funders
- American Heart Association (18CDA34110359)
- National Natural Science Foundation of China (81603339, 81602344)
- Javna Agencija za Raziskovalno Dejavnost RS (J3-8209)
- Centro de Investigación Biomédica en Red-Fisiopatología de la Obesidad y Nutrición (CB12/03/, CB12/03/30038)
- Natural Science Foundation of Anhui Province (1708085QH175)
- Instituto de Salud Carlos III (CB12/03/30038, CIBEROBN CB12/03/30038)
- Topics
- Health Sciences › Medicine › Pharmacology › Berberine and alkaloids research
- Health Sciences › Medicine › Complementary and alternative medicine › Traditional Chinese Medicine Analysis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Keywords
- berberine, cardiovascular disease, metabolic disorders, AMPK, SIRT1, LDL receptor, PCSK9, PTP1B, molecular targets, traditional Chinese medicine, Ayurveda, drug repurposing, therapeutic mechanisms
- MeSH terms
- Animals, Berberine, Cardiovascular Diseases, Cardiovascular System, Humans, Metabolic Diseases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review